Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
Isn’t part of the reason why GLP-1 drugs work so well, is because they do something that interferes with that “food drive”? I think it’s different than gastric bypass in that way
I think is the other way around. They extend the “I’m fullfil” hormone like from minutes to hours, so people don’t find themselves snacking an hour after eating
The gastric bypass helped lose weight fast, she kept it off for a while. I still don’t think she eats that much. Alcoholism is a beast of it’s own, I think she got disulfiram out of rehab to help.